Keunchil Park

Keunchil Park

UNVERIFIED PROFILE

Are you Keunchil Park?   Register this Author

Register author
Keunchil Park

Keunchil Park

Publications by authors named "Keunchil Park"

Are you Keunchil Park?   Register this Author

100Publications

2639Reads

12Profile Views

Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease.

Int J Cancer 2019 Nov 25;145(9):2433-2439. Epub 2019 Mar 25.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32235DOI Listing
November 2019

Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Korean J Intern Med 2019 Sep 20;34(5):1107-1115. Epub 2018 Jun 20.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2017.234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718762PMC
September 2019

DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC.

J Thorac Oncol 2019 Sep 22;14(9):1640-1650. Epub 2019 May 22.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Health Science and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.014DOI Listing
September 2019

Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor.

J Thorac Oncol 2019 Sep 11;14(9):1608-1618. Epub 2019 Jun 11.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.033DOI Listing
September 2019

Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.

Eur J Cancer 2019 Sep 4;120:65-74. Epub 2019 Sep 4.

Division of Hematology-Oncology, Departments of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.08.001DOI Listing
September 2019

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.

J Clin Oncol 2019 Aug 15;37(24):2162-2170. Epub 2018 Jun 15.

3Samsung Medical Center, Sunghyunkwan University School of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3184DOI Listing
August 2019

Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma.

Lung Cancer 2019 Aug 24;134:7-15. Epub 2019 May 24.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.024DOI Listing
August 2019

Predictive and Prognostic Value of F-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer.

Sci Rep 2019 Aug 21;9(1):12215. Epub 2019 Aug 21.

Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-48674-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704155PMC
August 2019

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea.

Cancer Res Treat 2019 Jul 26. Epub 2019 Jul 26.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2019.186DOI Listing
July 2019

Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor.

Clin Lung Cancer 2019 May 31;20(3):215-221. Epub 2018 Dec 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304183035
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2018.12.020DOI Listing
May 2019

Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients.

Clin Lung Cancer 2019 May 31;20(3):e309-e316. Epub 2018 Dec 31.

Department of Radiology, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.12.021DOI Listing
May 2019

Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma.

J Cancer Res Clin Oncol 2019 May 21;145(5):1341-1349. Epub 2019 Mar 21.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-02889-0DOI Listing
May 2019

Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.

J Immunother Cancer 2019 May 16;7(1):128. Epub 2019 May 16.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-Gu, Seoul, 60351, Republic of Korea.

View Article

Download full-text PDF

Source
https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0
Publisher Site
http://dx.doi.org/10.1186/s40425-019-0609-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524245PMC
May 2019

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.

Invest New Drugs 2019 May 24. Epub 2019 May 24.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-019-00795-3DOI Listing
May 2019

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.

Cancer Res Treat 2019 Apr 13;51(2):502-509. Epub 2018 Jun 13.

Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473268PMC
April 2019

Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea.

Cancer Res Treat 2019 Apr 23;51(2):623-631. Epub 2018 Jul 23.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2018.1
Publisher Site
http://dx.doi.org/10.4143/crt.2018.151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473281PMC
April 2019

The First-week Proliferative Response of Peripheral Blood PD-1CD8 T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors.

Clin Cancer Res 2019 Apr 15;25(7):2144-2154. Epub 2019 Jan 15.

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-1449DOI Listing
April 2019

Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?

Future Oncol 2019 Apr 13;15(12):1363-1383. Epub 2019 Feb 13.

Boehringer Ingelheim Pharma GmbH & Co, KG, Germany & Institute of Pharmacology, Johannes Gutenberg-University Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0948DOI Listing
April 2019

Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer.

Lung Cancer 2019 Apr 28;130:87-92. Epub 2019 Jan 28.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.01.012DOI Listing
April 2019

Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery.

Radiother Oncol 2019 Apr 21;133:87-92. Epub 2019 Jan 21.

Department of Radiation Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.01.005DOI Listing
April 2019

First-line afatinib for the treatment of mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting.

Ther Adv Med Oncol 2019 15;11:1758835919836374. Epub 2019 Apr 15.

Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835919836374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466470PMC
April 2019

Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer.

Eur J Nucl Med Mol Imaging 2019 02 25;46(2):446-454. Epub 2018 Aug 25.

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-018-4138-5DOI Listing
February 2019

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC.

J Thorac Oncol 2019 Feb 1;14(2):193-202. Epub 2018 Nov 1.

Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183338
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.10.150DOI Listing
February 2019

Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer.

Cancer Res Treat 2019 Jan 23;51(1):408-412. Epub 2018 May 23.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333983PMC
January 2019

Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion.

Radiat Oncol 2018 Dec 14;13(1):245. Epub 2018 Dec 14.

Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-018-1196-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295084PMC
December 2018

Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial.

Lung Cancer 2018 10 3;124:293-297. Epub 2018 Aug 3.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183051
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.08.003DOI Listing
October 2018

Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice.

J Thorac Oncol 2018 09 5;13(9):1373-1382. Epub 2018 Jun 5.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.026DOI Listing
September 2018

Low-power and low-drug-dose photodynamic chemotherapy via the breakdown of tumor-targeted micelles by reactive oxygen species.

J Control Release 2018 09 31;286:240-253. Epub 2018 Jul 31.

Department of Materials Science and Engineering, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea; KAIST Institute for the NanoCentury, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2018.07.046DOI Listing
September 2018

Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication.

J Thorac Oncol 2018 08;13(8):1106-1112

Division of Hematology-Oncology, Departments of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.038DOI Listing
August 2018

Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma.

Lung Cancer 2018 08 9;122:160-164. Epub 2018 Jun 9.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183041
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.06.009DOI Listing
August 2018

Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy.

Lung Cancer 2018 08 24;122:234-242. Epub 2018 May 24.

Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.05.023DOI Listing
August 2018

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.

PLoS One 2018 11;13(4):e0194730. Epub 2018 Apr 11.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194730PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895014PMC
July 2018

Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea.

Lung Cancer 2018 05 6;119:36-41. Epub 2018 Mar 6.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.02.020DOI Listing
May 2018

KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma.

J Thorac Oncol 2018 03 2;13(3):e29-e31. Epub 2017 Nov 2.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.014DOI Listing
March 2018

Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07).

Br J Cancer 2018 03 30;118(5):648-653. Epub 2018 Jan 30.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.465DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846070PMC
March 2018

Late-Onset Cholecystitis with Cholangitis after Avelumab Treatment in Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 03;13(3):e34-e36

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.007DOI Listing
March 2018

Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapy.

Lung Cancer 2018 03 6;117:7-13. Epub 2018 Jan 6.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.01.004DOI Listing
March 2018

Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach.

Sci Rep 2018 02 19;8(1):3284. Epub 2018 Feb 19.

Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-21706-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818618PMC
February 2018

A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2018 01 6;19(1):27-34. Epub 2017 Jul 6.

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.06.013DOI Listing
January 2018

Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 01 31;13(1):106-111. Epub 2017 Oct 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.011DOI Listing
January 2018

Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer.

Lung Cancer 2018 01 22;115:89-96. Epub 2017 Nov 22.

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.11.020DOI Listing
January 2018

Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 12 28;12(12):1806-1813. Epub 2017 Sep 28.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.09.1954DOI Listing
December 2017

Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?

Cancer Treat Rev 2017 Dec 25;61:70-81. Epub 2017 Oct 25.

Innovative Cancer Medicine Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372173015
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2017.10.003DOI Listing
December 2017

Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

J Clin Oncol 2017 Nov 13;35(32):3662-3670. Epub 2017 Sep 13.

Kaoru Kubota, Nippon Medical School; Kaori Hara and Takayuki Asato, Takeda Pharmaceutical, Tokyo; Hiroshige Yoshioka, Kurashiki Central Hospital, Kurashiki; Fumihiro Oshita, Kanagawa Prefectural Ashigarakami Hospital, Matsuda; Toyoaki Hida, Aichi Cancer Center Hospital, Nagoya; Kiyotaka Yoh, National Cancer Center Hospital East, Chiba; Hidetoshi Hayashi, Hiroyasu Kaneda, and Kazuhiko Nakagawa, Kindai University Faculty of Medicine; Hidetoshi Hayashi, Kishiwada Municipal Hospital, Osaka; Terufumi Kato, Kanagawa Cardiovascular and Respiratory Center, Yokohama; Kazuhiko Yamada, Kurume University School of Medicine; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hiroshi Tanaka, Niigata Cancer Center Hospital, Niigata, Japan; Keunchil Park, Samsung Biomedical Research Institute, Seoul; Eun Kyung Cho, Gachon University; Kyung-Hee Lee, Inha University Hospital, Incheon, South Korea; Chih-Bin Lin, Buddhist Tzu-Chi General Hospital, Hualien; James Chih-Hsin Yang, National Taiwan University Hospital; National Taiwan University Cancer Center, Taipei City, Peoples Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.7297DOI Listing
November 2017

Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer.

Cancer Res Treat 2017 Oct 26;49(4):906-914. Epub 2016 Dec 26.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2016.424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654158PMC
October 2017

Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea.

Asia Pac J Clin Oncol 2017 Oct 16;13(5):e239-e245. Epub 2017 Apr 16.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12645DOI Listing
October 2017

An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.

Expert Rev Mol Diagn 2017 10 30;17(10):933-942. Epub 2017 Aug 30.

b Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center , Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2017.1372196DOI Listing
October 2017

Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications.

Biomater Res 2017 17;21:21. Epub 2017 Oct 17.

Department of Materials Science and Engineering and KAIST Institute for the NanoCentury, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon, 34141 Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40824-017-0108-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645845PMC
October 2017

Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.

J Clin Oncol 2017 Sep 12;35(26):3065-3074. Epub 2017 May 12.

June-Koo Lee, Jeonghwan Youk, Seongyeol Park, Yohan An, Joon Kim, Young Seok Ju, Korea Advanced Institute of Science and Technology; Junehawk Lee, Korea Institute of Science and Technology Information, Daejeon; Sehui Kim, Bhumsuk Keam, Dong-Wan Kim, Dae Seog Heo, Young Tae Kim, Yoon Kyung Jeon, Doo Hyun Chung, Tae Min Kim, Seoul National University Hospital; Soyeon Kim, Bhumsuk Keam, Dong-Wan Kim, Dae Seog Heo, Young Tae Kim, Ja-Lok Ku, Yoon Kyung Jeon, Tae Min Kim, Seoul National University Cancer Research Institute; Jin-Soo Kim, Seoul Metropolitan Government-Seoul National University Boramae Medical Center; Se-Hoon Lee, Keunchil Park, Sungkyunkwan University School of Medicine; Doo Hyun Chung, Seoul National University College of Medicine, Seoul; Se Hyun Kim, Jong Seok Lee, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; and Peter J. Park, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.9096DOI Listing
September 2017

Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors.

Cancer Chemother Pharmacol 2017 Sep 21;80(3):591-598. Epub 2017 Jul 21.

Division of Hematology-Oncology, Departments of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3396-4DOI Listing
September 2017

Mutational status of defines the efficacy of Wee1 inhibitor AZD1775 in -mutant non-small cell lung cancer.

Oncotarget 2017 Sep 28;8(40):67526-67537. Epub 2017 Jun 28.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620191PMC
September 2017

A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma.

Cancer Res Treat 2017 Jul 9;49(3):816-823. Epub 2016 Nov 9.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2016.417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512359PMC
July 2017

Prospects and progress of atezolizumab in non-small cell lung cancer.

Expert Opin Biol Ther 2017 06 28;17(6):781-789. Epub 2017 Mar 28.

e US Oncology Thoracic Oncology Program , Virginia Cancer Specialists , Fairfax , VA 22031.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2017.1309389DOI Listing
June 2017

EGFR TKI combination with immunotherapy in non-small cell lung cancer.

Expert Opin Drug Saf 2017 Apr 8;16(4):465-469. Epub 2017 Mar 8.

a Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center , Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1300656DOI Listing
April 2017

Can we define the optimal sequence of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of epidermal growth factor receptor-mutant nonsmall cell lung cancer?

Curr Opin Oncol 2017 03;29(2):89-96

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000350DOI Listing
March 2017

Osimertinib for the treatment of non-small cell lung cancer.

Expert Opin Pharmacother 2017 Feb;18(2):225-231

a Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center , Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1285283DOI Listing
February 2017

Transient Asymptomatic Pulmonary Opacities during Osimertinib Treatment: "Stop or Go" Decision.

J Thorac Oncol 2016 12;11(12):2051-2052

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.09.130DOI Listing
December 2016

Afatinib for patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: clinical implications of the LUX-Lung 7 study.

Authors:
Keunchil Park

Ann Transl Med 2016 Dec;4(23):476

Division of Hematology/Oncology, Innovative Cancer Medicine Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2016.11.42DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220032PMC
December 2016

Outcomes of Gamma Knife Radiosurgery in Combination with Crizotinib for Patients with Brain Metastasis from Non-Small Cell Lung Cancer.

World Neurosurg 2016 Nov 24;95:399-405. Epub 2016 Aug 24.

Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2016.08.046DOI Listing
November 2016

A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma.

J Thorac Oncol 2016 10 21;11(10):1736-44. Epub 2016 Jul 21.

Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.05.038DOI Listing
October 2016

Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor.

Lung Cancer 2016 10 26;100:24-29. Epub 2016 Jul 26.

Departments of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002163042
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2016.07.025DOI Listing
October 2016

Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis.

Med Oncol 2016 Aug 22;33(8):97. Epub 2016 Jul 22.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-016-0811-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958121PMC
August 2016